Cervical Cancer Screening Test (HPV)
CervicalScreen, Easy to use at-home sample collection kit for cervical cancer screening. For women aged 25+.
Have you previously been diagnosed with cervical cancer or are you still having follow up for abnormal cells in the cervix?
- No need for a GP visit
- Full clinical advice, support and referral
- At-home sample collection kit
- Accurate results within 5 days
- Includes personalised screening programme
Why Cervical Screening is necessary?
Klarity’s cancer screening services are clinically governed by age restrictions, if you are not within the age range for a service you will not be able to sign up to that service. This is because clinical research does not support the benefits of screening people outside our specified age eligibilities. Regardless of age, if you have symptoms then you should always seek medical advice from your GP.
Why should I get checked for cervical cancer?
HPV is a virus that is extremely common, with four in five people exposed to the virus at some point in their lives through sexual transmission or intimate contact. It is also the leading cause of cervical cancer in women, with 99.7% of cervical cancers being caused by HPV.
The cervical cancer screening test?
You will receive a sterile collection kit, which is sent to your home, containing easy to follow step-by-step instructions. Complete the at-home test by following the simple instructions provided in the test kit. Return your sample to the laboratory and you can expect your results within five days of the laboratory receiving your sample. Your results will be available in your Klarity member’s page. One of our clinical team will contact you to discuss your results and assist with any questions you may have.
How does it work?
CervicalScreen is a reliable, easy to use at-home cervical cancer screening kit that detects the Human papillomavirus (HPV), the virus that causes cervical cancer. For 90% of women, using CervicalScreen means you may never need to have a smear test again. CervicalScreen tests for the 13 high-risk sub-types of HPV, identifying women potentially at a high risk of cervical cancer. The NHS does not currently report on HPV sub-types.
